EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors



Dual metalloprotease inhibitors. 6. Incorporation of bicyclic and substituted monocyclic azepinones as dipeptide surrogates in angiotensin-converting enzyme/neutral endopeptidase inhibitors



Journal of Medicinal Chemistry 39(2): 494-502



A series of substituted monocyclic and bicyclic azepinones were incorporated as dipeptide surrogates in mercaptoacetyl dipeptides with the desire to generate a single compound which would potently inhibit both angiotensin-converting enzyme (ACE) and neutral endopeptidase (NEP). Many of these compounds displayed excellent potency against both enzymes. Two of the most potent compounds, monocyclic azepinone 2n and bicyclic azepinone 3q, demonstrated a high level of activity versus ACE and NEP both in vitro and in vivo.

(PDF emailed within 0-6 h: $19.90)

Accession: 008505644

Download citation: RISBibTeXText

PMID: 8558518

DOI: 10.1021/jm950677a



Related references

Dual metalloprotease inhibitors: mercaptoacetyl-based fused heterocyclic dipeptide mimetics as inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Journal of Medicinal Chemistry 40(11): 1570-1577, 1997

New alpha-thiol dipeptide dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase EC 3.4.24.11. Journal of Medicinal Chemistry 38(26): 5023-5030, 1995

New .alpha.-Thiol Dipeptide Dual Inhibitors of Angiotensin-I-Converting Enzyme and Neutral Endopeptidase EC 3.4.24.11. Journal of Medicinal Chemistry 38(26): 5023-5030, 1995

Vasopeptidase inhibitors, neutral endopeptidase inhibitors, and dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Heart Disease 3(6): 378-385, 2002

Angiotensin converting enzyme inhibitors: N-substituted monocyclic and bicyclic amino acid derivatives. Journal of Medicinal Chemistry 26(9): 1267-1277, 1983

In vivo pharmacology of dual neutral endopeptidase/angiotensin-converting enzyme inhibitors. Journal of Cardiovascular Pharmacology 28(5): 672-678, 1996

Dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase Design and therapeutic rationale. Laragh, J H , Brenner, B M Hypertension: Pathophysiology, diagnosis, and management, Second edition, Vols 1 and 2 3099-3114, 1995

Heterocyclic lactam derivatives as dual angiotensin converting enzyme and neutral endopeptidase 24.11 inhibitors. Journal of Medicinal Chemistry 36(24): 3829-3833, 1993

Diamino propionic acid derivatives dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme. Abstracts of Papers American Chemical Society 210(1-2): MEDI 65, 1995

Mercaptoacyl dipeptides as orally active dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase. Journal of Medicinal Chemistry 39(16): 3158-3168, 1996

C-terminal tryptophan dipeptides Orally active dual inhibitors of angiotensin-I converting enzyme and neutral endopeptidase. Abstracts of Papers American Chemical Society 212(1-2): MEDI 168, 1996

Mercaptoacyl dipeptides as dual inhibitors of angiotensin-converting enzyme and neutral endopeptidase: Preliminary structure-activity studies. Bioorganic and Medicinal Chemistry Letters 4(15): 1783-1788, 1994

Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action. Journal of Medicinal Chemistry 39(13): 2594-2608, 1996

Section Review: Cardiovascular & Renal: Recent advances in the development of dual angiotensin-converting enzyme and neutral endopeptidase inhibitors. Expert Opinion on Therapeutic Patents 6(11): 1147-1164, 1996

New dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme: Rational design, bioavailability, and pharmacological responses in experimental hypertension. Journal of Medicinal Chemistry 37(8): 1070-1083, 1994